Women's Health

>

Latest News

Decrease in MHT Use over Past 2 Decades: Daily Dose / image credit: ©New Africa/AdobeStock
Decrease in MHT Use over Past 2 Decades: Daily Dose

October 10th 2024

Your daily dose of the clinical news you may have missed.

Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose / image credit: ©New Africa/AdobeStock
Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose

October 9th 2024

Menopausal Hormone Therapy Use Declined in Past 2 Decades among Women Regardless of Age, Race/Ethnicity / Image credit: ©Vitalii Vodolazskyi/AdobeStock
Menopausal Hormone Therapy Use Declined in Past 2 Decades among Women Regardless of Age, Race/Ethnicity

September 27th 2024

Better CV Health in Early Pregnancy Offsets High Genetic Risk: Daily Dose / image credit: ©New Africa/AdobeStock
Better CV Health in Early Pregnancy Offsets High Genetic Risk: Daily Dose

September 27th 2024

Preconception Prediabetes Ups Risk for Poor Pregnancy Outcomes in Young Women: New Data / image credit gestational diabetes concept:©arturfoto/stock.adobe.com
Preconception Prediabetes Ups Risk for Poor Pregnancy Outcomes in Young Women: New Data

September 25th 2024

Latest CME Events & Activities

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances...

October 10, 2024

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

2024 Neuromuscular Summit

November 20, 2024

View More

Medical Crossfire®: Finding The Right Place for Immunotherapy and Targeted Treatments in the Management of Endometrial Cancer

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

May 3, 2025

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.